Flu activity in the United States is finally slowing down, but health experts say this year’s flu vaccine didn't offer as ...

Viral mismatch between circulating strains and vaccine may have weighed down effectiveness ...

As the U.S. flu season winds down, health officials say the flu vaccine didn’t work very well, with one of its worst ...

The US FDA’s vaccine advisors have recommended that three new influenza strains be included in next winter’s influenza vaccine, aiming in part to tamp down illness caused by subclade K, a mutated form ...

A little-known virus that causes nasty flu-like symptoms is spreading in California — and it doesn’t have a vaccine. Cases of human metapneumovirus (HMPV) have been steadily rising since winter began, ...

A New York City resident was diagnosed with clade I mpox after recent travel to Europe The NYC Health Department is advising ...

FINGER LAKES, N.Y. — As flu season comes to a close, health officials reported that this year’s vaccine was not very effective. News10NBC covered the high flu rates across the Finger Lakes region.

European regulators cleared Moderna’s first-of-its-kind vaccine as US approval remains uncertain. On Friday, Moderna’s mCombriax—a combined vaccine for both the flu and COVID—was recommended for ...

Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...

FDA advisers recommend fall flu shot changes to include the new subclade K H3N2 variant for the 2026-27 season, improving vaccine relevance.

Currently there is no vaccine to prevent this virus and no specific antiviral therapy to treat HMPV, according to the CDC.

The FDA is slated to make a decision on the flu shot on Aug. 5, which will allow Moderna to make the vaccine available for the upcoming influenza season.